Projects per year
Personal profile
Research interests
Research Expertise:
Organic & Medicinal Chemistry | Organoboron Chemistry | Alternate Energy Materials
Medicinal Chemistry: We have been developing novel aza- and bora-heterocyclic compounds and betulin-based natural product derivatives as anti-cancer agents. In collaboration with Rowan School of Osteopathic Medicine, we have also identified few Withaferin-serotonin conjugates as potential therapeutic options for the treatment of Alzheimers’ Disease.
Value Added Chemicals from Biomass: Recent efforts in this area have included the development of new protocols for the effective conversion of biomass derived cellulosic materials into chemicals such as hydroxymethyl furfural and furan dicarboxylic acid for applications as bio-based polymers.
Honors and Awards:
Rowan University Wall of Fame Teaching Award, 2013, 2016
Eli Lilly International Graduate Scholar, 2000-2005, Purdue University
Member of:
American Chemical Society (www.acs.org)
Education/Academic qualification
Doctor of Philosophy, doctorate
Bachelor of Science, Bachelor, Pondicherry University
Master of Science, Master, University of Hyderabad
Fingerprint
Dive into the research topics where Subash Jonnalagadda is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Development of Novel Small Molecules as Potential Anti-Cancer Agents
1/1/15 → 6/30/23
Project: Research project
-
Research and Development of Topical and Intravenous Formulations
6/1/16 → 5/31/17
Project: Other project
-
-
Preparation and Purification of Biologically Relevant Natural Products
Rosenberg Integrative Cancer Treatment and Research Institute
1/1/15 → 12/21/15
Project: Research project
-
Bruton’s tyrosine kinase targeting in multiple myeloma
Suskil, M. V., Sultana, K. N., Elbezanti, W. O., Al-Odat, O. S., Chitren, R., Tiwari, A. K., Challagundla, K. B., Srivastava, S. K., Jonnalagadda, S. C., Budak-Alpdogan, T. & Pandey, M. K., Jun 1 2021, In: International Journal of Molecular Sciences. 22, 11, 5707.Research output: Contribution to journal › Review article › peer-review
Open Access3 Scopus citations -
Mcl-1 Inhibition: Managing Malignancy in Multiple Myeloma
Al-Odat, O., von Suskil, M., Chitren, R., Elbezanti, W., Srivastava, S., Budak-Alpddogan, T., Jonnalagadda, S., Aggarwal, B. & Pandey, M., Jul 19 2021, In: Frontiers in Pharmacology. 12, 699629.Research output: Contribution to journal › Review article › peer-review
Open Access2 Scopus citations -
Old drugs, new uses: Drug repurposing in hematological malignancies
Kale, V. P., Habib, H., Chitren, R., Patel, M., Pramanik, K. C., Jonnalagadda, S. C., Challagundla, K. & Pandey, M. K., Jan 2021, In: Seminars in Cancer Biology. 68, p. 242-248 7 p.Research output: Contribution to journal › Review article › peer-review
14 Scopus citations -
Nucleic acid delivery with α-tocopherol-polyethyleneimine-polyethylene glycol nanocarrier system
Nawshad Hossian, A. K. M., Jois, S. D., Jonnalagadda, S. C. & Mattheolabakis, G., 2020, In: International Journal of Nanomedicine. 15, p. 6689-6703 15 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Synthesis, in vitro, and in vivo evaluation of novel N-phenylindazolyl diarylureas as potential anti-cancer agents
Solano, L. N., Nelson, G. L., Ronayne, C. T., Jonnalagadda, S., Jonnalagadda, S. K., Kottke, K., Chitren, R., Johnson, J. L., Pandey, M. K., Jonnalagadda, S. C. & Mereddy, V. R., Dec 1 2020, In: Scientific Reports. 10, 1, 17969.Research output: Contribution to journal › Article › peer-review
Open Access4 Scopus citations